{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T07:53:24Z","timestamp":1656057204962},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00120-018-0830-0","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T14:02:42Z","timestamp":1547647362000},"page":"25-29","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Instillationstherapien beim Urothelkarzinom des oberen Harntraktes"],"prefix":"10.1007","volume":"58","author":[{"given":"P.","family":"Bosshard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. N.","family":"Thalmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,16]]},"reference":[{"key":"830_CR1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4103\/0974-7796.115746","volume":"5","author":"OM Aboumarzouk","year":"2013","unstructured":"Aboumarzouk OM, Somani B, Ahmad S et\u00a0al (2013) Mitomycin C instillation following ureterorenoscopic laser ablation of upper urinary tract carcinoma. Urol Ann 5:184\u2013189","journal-title":"Urol Ann"},{"key":"830_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.juro.2010.03.032","volume":"184","author":"DC Chade","year":"2010","unstructured":"Chade DC, Shariat SF, Godoy G et\u00a0al (2010) Clinical outcomes of primary bladder carcinoma in situ in a\u00a0contemporary series. J\u00a0Urol 184:74\u201380","journal-title":"J Urol"},{"key":"830_CR3","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0022-5347(05)67135-2","volume":"164","author":"GL Chen","year":"2000","unstructured":"Chen GL, Bagley DH (2000) Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J\u00a0Urol 164:1173\u20131176","journal-title":"J Urol"},{"key":"830_CR4","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1111\/j.1464-410X.2012.11169.x","volume":"110","author":"ML Cutress","year":"2012","unstructured":"Cutress ML, Stewart GD, Wells-Cole S et al (2012) Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience. BJU Int 110:1608\u20131617","journal-title":"BJU Int"},{"key":"830_CR5","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1464-410X.2012.11068.x","volume":"110","author":"ML Cutress","year":"2012","unstructured":"Cutress ML, Stewart GD, Zakikhani P et\u00a0al (2012) Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU Int 110:614\u2013628","journal-title":"BJU Int"},{"key":"830_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/cncr.11446","volume":"98","author":"S Daneshmand","year":"2003","unstructured":"Daneshmand S, Quek ML, Huffman JL (2003) Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience. Cancer 98:55\u201360","journal-title":"Cancer"},{"key":"830_CR7","volume-title":"2018 edition","author":"European Association of Urology Guidelines","year":"2018","unstructured":"European Association of Urology Guidelines (2018) EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS) 2018. In: 2018 edition. European Association of Urology Guidelines Office, Arnhem"},{"key":"830_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000350508","volume":"91","author":"D Fang","year":"2013","unstructured":"Fang D, Li XS, Xiong GY et al (2013) Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a\u00a0systematic review and meta-analysis. Urol Int 91:291\u2013296","journal-title":"Urol Int"},{"key":"830_CR9","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.juro.2010.02.005","volume":"183","author":"AJ Gadzinski","year":"2010","unstructured":"Gadzinski AJ, Roberts WW, Faerber GJ et al (2010) Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J\u00a0Urol 183:2148\u20132153","journal-title":"J Urol"},{"key":"830_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.eururo.2011.07.051","volume":"60","author":"G Giannarini","year":"2011","unstructured":"Giannarini G, Kessler TM, Birkhauser FD et al (2011) Antegrade perfusion with bacillus Calmette-Guerin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? Eur Urol 60:955\u2013960","journal-title":"Eur Urol"},{"key":"830_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0090-4295(99)00121-1","volume":"54","author":"M Grasso","year":"1999","unstructured":"Grasso M, Fraiman M, Levine M (1999) Ureteropyeloscopic diagnosis and treatment of upper urinary tract urothelial malignancies. Urology 54:240\u2013246","journal-title":"Urology"},{"key":"830_CR12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0022-5347(17)47277-6","volume":"134","author":"HW Herr","year":"1985","unstructured":"Herr HW (1985) Durable response of a\u00a0carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin. J\u00a0Urol 134:531\u2013532","journal-title":"J Urol"},{"key":"830_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12032-018-1102-y","volume":"35","author":"H Horiguchi","year":"2018","unstructured":"Horiguchi H, Yoneyama T, Hatakeyama S et al (2018) Impact of bacillus Calmette-Guerin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy. Med Oncol 35:41","journal-title":"Med Oncol"},{"key":"830_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1470-2045(06)70803-8","volume":"7","author":"WC Huang","year":"2006","unstructured":"Huang WC, Levey AS, Serio AM et\u00a0al (2006) Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a\u00a0retrospective cohort study. Lancet Oncol 7:735\u2013740","journal-title":"Lancet Oncol"},{"key":"830_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0090-4295(01)01488-1","volume":"59","author":"A Irie","year":"2002","unstructured":"Irie A, Iwamura M, Kadowaki K et al (2002) Intravesical instillation of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a\u00a0double-pigtail catheter. Urology 59:53\u201357","journal-title":"Urology"},{"key":"830_CR16","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/S0022-5347(01)66732-6","volume":"154","author":"TW Jarrett","year":"1995","unstructured":"Jarrett TW, Sweetser PM, Weiss GH et al (1995) Percutaneous management of transitional cell carcinoma of the renal collecting system: 9\u2011year experience. J\u00a0Urol 154:1629\u20131635","journal-title":"J Urol"},{"key":"830_CR17","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.juro.2013.09.031","volume":"191","author":"LM Krabbe","year":"2014","unstructured":"Krabbe LM, Lotan Y, Bagrodia A et\u00a0al (2014) Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract\u2014is there evidence for discordant biology? J\u00a0Urol 191:926\u2013931","journal-title":"J Urol"},{"key":"830_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0022-5347(01)65854-3","volume":"156","author":"JA Martinez-Pineiro","year":"1996","unstructured":"Martinez-Pineiro JA, Garcia Matres MJ, Martinez-Pineiro L (1996) Endourological treatment of upper tract urothelial carcinomas: analysis of a\u00a0series of 59 tumors. J\u00a0Urol 156:377\u2013385","journal-title":"J Urol"},{"key":"830_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW (1976) Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J\u00a0Urol 116:180\u2013183","journal-title":"J Urol"},{"key":"830_CR20","doi-asserted-by":"publisher","first-page":"45e23","DOI":"10.1016\/j.urolonc.2013.06.008","volume":"32","author":"R Nunez-Nateras","year":"2014","unstructured":"Nunez-Nateras R, Castle EP, Protheroe CA et al (2014) Predicting response to bacillus Calmette-Guerin (BCG) in patients with carcinoma in situ of the bladder. Urol Oncol 32:45e23\u201345e30","journal-title":"Urol Oncol"},{"issue":"10","key":"830_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","volume":"15","author":"C Pettenati","year":"2018","unstructured":"Pettenati C, Ingersoll MA (2018) Mechanisms of BCG immunotherapy and its outlook for bladder cancer. Nat Rev Urol 15(10):615","journal-title":"Nat Rev Urol"},{"key":"830_CR22","doi-asserted-by":"publisher","first-page":"1451.e1","DOI":"10.1016\/j.urology.2013.08.048","volume":"82","author":"ME Pollard","year":"2013","unstructured":"Pollard ME, Levinson AW, Shapiro EY et\u00a0al (2013) Comparison of 3 upper tract anticarcinogenic agent delivery techniques in an ex vivo porcine model. Urology 82:1451.e1\u20131451.e6","journal-title":"Urology"},{"key":"830_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/end.2010.0276","volume":"25","author":"EM Raymundo","year":"2011","unstructured":"Raymundo EM, Lipkin ME, Banez LB et al (2011) Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma. J\u00a0Endourol 25:377\u2013384","journal-title":"J Endourol"},{"key":"830_CR24","volume-title":"2018 edition","author":"M Roupr\u00eat","year":"2018","unstructured":"Roupr\u00eat M, Babjuk M, Burger M et\u00a0al (2018) EAU guidelines on upper urinary tract urothelial carcinoma 2018. In: European Association of Urology (Hrsg) 2018 edition. European Association of Urology Guidelines Office, Arnhem"},{"key":"830_CR25","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.urology.2005.12.034","volume":"67","author":"M Roupret","year":"2006","unstructured":"Roupret M, Hupertan V, Traxer O et\u00a0al (2006) Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology 67:1181\u20131187","journal-title":"Urology"},{"key":"830_CR26","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.eururo.2015.07.039","volume":"68","author":"JP Sfakianos","year":"2015","unstructured":"Sfakianos JP, Cha EK, Iyer G et\u00a0al (2015) Genomic characterization of upper tract urothelial carcinoma. Eur Urol 68:970\u2013977","journal-title":"Eur Urol"},{"key":"830_CR27","first-page":"819470","volume":"2013","author":"I Sorokin","year":"2013","unstructured":"Sorokin I, Welliver RC Jr., Elkadi O et\u00a0al (2013) Tumor seeding of percutaneous nephrostomy tract from urothelial carcinoma of the kidney. Case Rep Urol 2013:819470","journal-title":"Case Rep Urol"},{"key":"830_CR28","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/S0022-5347(05)64454-0","volume":"168","author":"GN Thalmann","year":"2002","unstructured":"Thalmann GN, Markwalder R, Walter B et al (2002) Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J\u00a0Urol 168:1381\u20131385","journal-title":"J Urol"},{"key":"830_CR29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.urology.2007.11.018","volume":"71","author":"RH Thompson","year":"2008","unstructured":"Thompson RH, Krambeck AE, Lohse CM et\u00a0al (2008) Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. Urology 71:713\u2013717","journal-title":"Urology"},{"key":"830_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1464-410X.2012.11649.x","volume":"112","author":"E Xylinas","year":"2013","unstructured":"Xylinas E, Rink M, Margulis V et al (2013) Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int 112:453\u2013461","journal-title":"BJU Int"},{"key":"830_CR31","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.ejso.2014.06.007","volume":"40","author":"R Yakoubi","year":"2014","unstructured":"Yakoubi R, Colin P, Seisen T et al (2014) Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a\u00a0meta-analysis and a\u00a0systematic review of current evidence from comparative studies. Eur J Surg Oncol 40:1629\u20131634","journal-title":"Eur J Surg Oncol"},{"key":"830_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1755-8794-3-58","volume":"3","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Furge KA, Yang XJ et\u00a0al (2010) Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder. BMC Med Genomics 3:58","journal-title":"BMC Med Genomics"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-018-0830-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-018-0830-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-018-0830-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:16:03Z","timestamp":1579133763000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-018-0830-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["830"],"URL":"https:\/\/doi.org\/10.1007\/s00120-018-0830-0","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"16 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Bosshard, G.N.\u00a0Thalmann und B.\u00a0Roth geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}